Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer

Purpose. In the present study, the prognostic significance of CpG island methylator phenotype (CIMP) in stage II/III sporadic colorectal cancer was evaluated using a five-gene panel. Methods. Fifty stage II/III colorectal cancer patients who received radical resection were included in this study. Pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuwei Wang, Yadong Long, Ye Xu, Zuqing Guan, Peng Lian, Junjie Peng, Sanjun Cai, Guoxiang Cai
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2014/436985
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548575796527104
author Yuwei Wang
Yadong Long
Ye Xu
Zuqing Guan
Peng Lian
Junjie Peng
Sanjun Cai
Guoxiang Cai
author_facet Yuwei Wang
Yadong Long
Ye Xu
Zuqing Guan
Peng Lian
Junjie Peng
Sanjun Cai
Guoxiang Cai
author_sort Yuwei Wang
collection DOAJ
description Purpose. In the present study, the prognostic significance of CpG island methylator phenotype (CIMP) in stage II/III sporadic colorectal cancer was evaluated using a five-gene panel. Methods. Fifty stage II/III colorectal cancer patients who received radical resection were included in this study. Promoter methylation of p14ARF, hMLH1, p16INK4a, MGMT, and MINT1 was determined by methylation specific polymerase chain reaction (MSP). CIMP positive was defined as hypermethylation of three or more of the five genes. Impact factors on disease-free survival (DFS) and overall survival (OS) were analyzed using Kaplan-Meier method (log-rank test) and adjusted Cox proportional hazards model. Results. Twenty-four percent (12/50) of patients were characterized as CIMP positive. Univariate analysis showed stage III (P=0.049) and CIMP positive (P=0.014) patients who had significantly inferior DFS. In Cox regression analysis, CIMP positive epigenotype was independently related with poor DFS with HR = 2.935 and 95% CI: 1.193–7.220 (P=0.019). In patients with CIMP positive tumor, those receiving adjuvant chemotherapy had a poor DFS than those without adjuvant chemotherapy (P=0.023). Conclusions. CIMP positive was significantly correlated with decreased DFS in stage II/III colorectal cancer. Patients with CIMP positive locally advanced sporadic colorectal cancers may not benefit from 5-fluorouracil based adjuvant chemotherapy.
format Article
id doaj-art-eada09d6c4984be5847a663b4e1ea31d
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-eada09d6c4984be5847a663b4e1ea31d2025-02-03T06:13:48ZengWileyGastroenterology Research and Practice1687-61211687-630X2014-01-01201410.1155/2014/436985436985Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal CancerYuwei Wang0Yadong Long1Ye Xu2Zuqing Guan3Peng Lian4Junjie Peng5Sanjun Cai6Guoxiang Cai7Department of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaDepartment of Colorectal Surgery, Fudan University, 270 Dong An Road, Shanghai 200032, ChinaPurpose. In the present study, the prognostic significance of CpG island methylator phenotype (CIMP) in stage II/III sporadic colorectal cancer was evaluated using a five-gene panel. Methods. Fifty stage II/III colorectal cancer patients who received radical resection were included in this study. Promoter methylation of p14ARF, hMLH1, p16INK4a, MGMT, and MINT1 was determined by methylation specific polymerase chain reaction (MSP). CIMP positive was defined as hypermethylation of three or more of the five genes. Impact factors on disease-free survival (DFS) and overall survival (OS) were analyzed using Kaplan-Meier method (log-rank test) and adjusted Cox proportional hazards model. Results. Twenty-four percent (12/50) of patients were characterized as CIMP positive. Univariate analysis showed stage III (P=0.049) and CIMP positive (P=0.014) patients who had significantly inferior DFS. In Cox regression analysis, CIMP positive epigenotype was independently related with poor DFS with HR = 2.935 and 95% CI: 1.193–7.220 (P=0.019). In patients with CIMP positive tumor, those receiving adjuvant chemotherapy had a poor DFS than those without adjuvant chemotherapy (P=0.023). Conclusions. CIMP positive was significantly correlated with decreased DFS in stage II/III colorectal cancer. Patients with CIMP positive locally advanced sporadic colorectal cancers may not benefit from 5-fluorouracil based adjuvant chemotherapy.http://dx.doi.org/10.1155/2014/436985
spellingShingle Yuwei Wang
Yadong Long
Ye Xu
Zuqing Guan
Peng Lian
Junjie Peng
Sanjun Cai
Guoxiang Cai
Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
Gastroenterology Research and Practice
title Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
title_full Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
title_fullStr Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
title_full_unstemmed Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
title_short Prognostic and Predictive Value of CpG Island Methylator Phenotype in Patients with Locally Advanced Nonmetastatic Sporadic Colorectal Cancer
title_sort prognostic and predictive value of cpg island methylator phenotype in patients with locally advanced nonmetastatic sporadic colorectal cancer
url http://dx.doi.org/10.1155/2014/436985
work_keys_str_mv AT yuweiwang prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT yadonglong prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT yexu prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT zuqingguan prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT penglian prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT junjiepeng prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT sanjuncai prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer
AT guoxiangcai prognosticandpredictivevalueofcpgislandmethylatorphenotypeinpatientswithlocallyadvancednonmetastaticsporadiccolorectalcancer